As copay issues reportedly resolve for Americans receiving this season's updated COVID-19 vaccine, nursing homes and pediatric officers are struggling as demand exceeds supply.
Three things to know about the COVID-19 shot rollout:
1. In mid-September, some insurance plans weren't prepared to fully cover the cost of Pfizer's and Moderna's shots, which are no longer financially supported by the federal government and cost up to $190 each. Executives of private payers said in late September that the problem was fixed.
2. Pharmacies and nursing homes are facing difficulties in stocking enough vaccines amid bumps in the new distribution model, which changed from federal entities to wholesalers and other for-profit suppliers.
3. Pediatric formulations of the vaccine are in short supply, The Washington Post reported Oct. 2. Pediatricians told the outlet the issue is because Pfizer increased its minimum order requirement and they're unsure how much insurers will reimburse them.